Clauson Kevin A, Khanfar Nile M, Polen Hyla H, Gibson Florencetta
Pharmacy Practice, Nova Southeastern University, College of Pharmacy, West Palm Beach, FL, USA.
J Clin Nurs. 2009 Jan;18(2):228-33. doi: 10.1111/j.1365-2702.2008.02536.x.
The aim of our study was to investigate the perceptions of pharmaceutical sales representatives by nurse prescribers.
Nurses with advanced training have earned prescriptive authority in North America, Europe and other parts of the world. These nurses are being increasingly targeted by pharmaceutical sales representatives. There is a paucity of data regarding nurses' perceptions of pharmaceutical sales representatives.
Survey.
A convenience sample of nurse prescribers was recruited to complete an Internet questionnaire about their interactions with and perceptions of sales representatives. The data were collected over one month ending in January 2007. There were 39 survey items ranging from perception-based items assessed by Likert-type scale to open-ended queries. Descriptive statistics were used to summarise the results.
Ninety-two nurses completed this survey, which demonstrated good internal consistency yielding a Cronbach's alpha coefficient of 0.83. Positive perceptions of pharmaceutical representatives included: explaining their products clearly (80.4%) and knowledge about their medications (88.0%). Negative aspects included: lack of consideration of nurses' time (50%) and failure to equally discuss medication strengths and weaknesses (21.8%). Perhaps the most alarming finding was that 35.9% of respondents indicated that sales representatives suggested paybacks for promoting their drugs.
Nurses with prescriptive authority generally perceive interactions with pharmaceutical sales representatives as positive. However, they also have concerns about the nature and methods of some of their activities. Nations that have nurses with prescribing authority can benefit from observing both the mis-steps and the positive inroads that have already been made by the profession in the USA and other countries.
Appropriate use of pharmaceutical sales representatives' services may enhance the ability of nurse prescribers to deliver optimal nursing care. Methods, such as counter-detailing may be necessary to maintain an evidence-based approach as the controlling factor.
我们研究的目的是调查护士处方者对药品销售代表的看法。
经过高级培训的护士在北美、欧洲和世界其他地区已获得处方权。这些护士越来越成为药品销售代表的目标。关于护士对药品销售代表看法的数据很少。
调查。
招募了一个方便样本的护士处方者,以完成一份关于他们与销售代表互动及看法的网络问卷。数据收集期为截至2007年1月的一个月。有39个调查项目,从通过李克特量表评估的基于看法的项目到开放式问题。使用描述性统计来总结结果。
92名护士完成了这项调查,结果显示内部一致性良好,克朗巴哈系数为0.83。对药品代表的积极看法包括:清晰解释产品(80.4%)和对其药物的了解(88.0%)。消极方面包括:不考虑护士的时间(50%)和未能平等讨论药物的优缺点(21.8%)。也许最令人担忧的发现是,35.9%的受访者表示销售代表建议为推广其药物给予回扣。
有处方权的护士总体上认为与药品销售代表的互动是积极的。然而,他们也对其中一些活动的性质和方式感到担忧。拥有护士处方权的国家可以从观察美国和其他国家该行业已经出现的失误和积极进展中受益。
合理利用药品销售代表的服务可能会提高护士处方者提供最佳护理的能力。可能需要采用反宣传等方法来维持以证据为基础的方法作为控制因素